The US has slapped up to 100% tariffs on patented drugs, sparing generics and biosimilars but exposing India’s speciality pharma players. S...

Kuku FM and Kuku TV are venturing into movie theaters. Their first Hindi film, Indian Institute of Zombies, is a campus comedy. It blends h...

Ixigo, led by co-founder Aloke Bajpai, made a strong debut on Dalal Street with its shares closing 78% higher than the issue price, valuing...

While we select stocks based on our algorithms in a non-discretionary manner, we can divide the team using three major types of stocks. One...

The company is going through the process of capital restructuring through a 'scheme of arrangement' with its shareholders approved by Natio...

Sebi is investigating whether there have been instances of circular trading in the two stocks, the two people said.

Stocks from among those that traded below Rs 10 have burst forth to deliver eye-popping gains.

Let’s check out what all might influence Dalal Street through the day.

Listen in! Who moved your market today

Pharmaceutical companies have corrected sharply from their highs but it is difficult to say that the worst is behind.

A fresh spike in oil prices outweighed concerns over the outcome of Fed’s rate-setting and drove D-St, as investors somehow digested India'...

Indian drug makers may be receiving an increasing number of approvals from the USFDA for drug launches in the United States.

Despite a 12% growth in revenues at Rs 14,819 crore, the company ended up with a marginal growth of 3% in net profit at Rs 2,218 crore.

The global generics business, which contributes 82 per cent of total revenues, grew 8 per cent at Rs 3,169 crore.

In April, Lupin formed a joint venture with Japan’s Yoshindo for biosimilars. It is also in talks with other local drug makers for alliance...

With effect from August 8, the Latin American nation has included India on the list of countries that can supply medicines to it.

Sanofi had submitted its application to seek US Food and Drug Administration's (USFDA's) approval for its generic version of the drug on Ja...